secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001104659-24-063416
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio appoints Greg Firestone as CCO, replaces Peter Murphy terminated without cause
--------------------------------------------------------------------------------

- Greg Firestone appointed Chief Commercial Officer effective May 20, 2024; previously Chief Business Officer since October 2017.
- Peter Murphy terminated as CCO without cause on May 19, 2024; will receive severance per his employment agreement.
- Firestone will oversee commercial operations, product launches, sales training, and market access strategy.
- Firestone brings 35+ years of healthcare experience, including founding the IDN Summit & Expo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465924063416/0001104659-24-063416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465924063416/tm2414892d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-063416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer